GameSquare Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GameSquare Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.00M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $27.54M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $41.30M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $28.08M | Apr 16, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.00M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $27.54M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $41.30M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $28.08M | Apr 16, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.52M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $9.45M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $10.10M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $9.66M | Apr 16, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($40.10M) | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | ($48.75M) | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | ($31.28M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($18.12M) | Apr 16, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($25.24M) | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | ($34.37M) | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | ($25.38M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($18.25M) | Apr 16, 2024 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.05M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $1.89M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $3.07M | Apr 15, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($18.40M) | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | ($30.57M) | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | ($16.08M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($11.92M) | Apr 16, 2024 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.1K | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $5.1K | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $2.2K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $31.3K | Apr 16, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $79.30M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $78.73M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $64.71M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $20.20M | Apr 16, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.65M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $66.73M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | $46.35M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $12.94M | Apr 16, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.65M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $12.00M | Apr 8, 2026 |
| FY2025 | Dec 31, 2023 | $18.36M | Apr 8, 2026 |
| FY2023 | Dec 31, 2022 | $7.27M | Apr 16, 2024 |
| FY2023 | Dec 31, 2021 | $17.69M | Apr 16, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.91M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | $12.70M | Apr 8, 2026 |
| FY2025 | Dec 31, 2023 | $16.30M | Apr 8, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($162.27M) | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | ($122.17M) | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | ($73.42M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($42.14M) | Apr 16, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | (2) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | (3) | Apr 16, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | (2) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | (3) | Apr 16, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 98.07M | Apr 8, 2026 |
| FY2025 | Dec 31, 2024 | 32.64M | Apr 8, 2026 |
| FY2024 | Dec 31, 2023 | 12.99M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 6.35M | Apr 16, 2024 |